FR2910M - New injectable form of phenyl-1-dimethyl-2,3-dimethylamino-4-pyrazolone-5 ortho-hydroxyquinoline sulfonate useful in influenza and antirhumastimal therapy. - Google Patents

New injectable form of phenyl-1-dimethyl-2,3-dimethylamino-4-pyrazolone-5 ortho-hydroxyquinoline sulfonate useful in influenza and antirhumastimal therapy.

Info

Publication number
FR2910M
FR2910M FR940455A FR940455A FR2910M FR 2910 M FR2910 M FR 2910M FR 940455 A FR940455 A FR 940455A FR 940455 A FR940455 A FR 940455A FR 2910 M FR2910 M FR 2910M
Authority
FR
France
Prior art keywords
antirhumastimal
pyrazolone
influenza
ortho
dimethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR940455A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Causyth Chim Farm
Laboratorio Chimico Farmaceutico Causyth SpA
Original Assignee
Causyth Chim Farm
Laboratorio Chimico Farmaceutico Causyth SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Causyth Chim Farm, Laboratorio Chimico Farmaceutico Causyth SpA filed Critical Causyth Chim Farm
Application granted granted Critical
Publication of FR2910M publication Critical patent/FR2910M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR940455A 1967-05-18 1963-07-05 New injectable form of phenyl-1-dimethyl-2,3-dimethylamino-4-pyrazolone-5 ortho-hydroxyquinoline sulfonate useful in influenza and antirhumastimal therapy. Expired FR2910M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH701567A CH487897A (en) 1967-05-18 1967-05-18 Process for the preparation of a water-soluble complex of the 8-hydroxy-quinoline - (- sulfonate of 1,5-dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolone

Publications (1)

Publication Number Publication Date
FR2910M true FR2910M (en) 1964-11-09

Family

ID=4318592

Family Applications (1)

Application Number Title Priority Date Filing Date
FR940455A Expired FR2910M (en) 1967-05-18 1963-07-05 New injectable form of phenyl-1-dimethyl-2,3-dimethylamino-4-pyrazolone-5 ortho-hydroxyquinoline sulfonate useful in influenza and antirhumastimal therapy.

Country Status (4)

Country Link
BE (1) BE629650A (en)
CH (1) CH487897A (en)
FR (1) FR2910M (en)
GB (1) GB1072359A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093999A2 (en) * 1982-05-08 1983-11-16 Gödecke Aktiengesellschaft Pharmaceutical formulations of oxicam derivatives, and process for preparing them

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437232A1 (en) * 1984-10-10 1986-04-17 Mack Chem Pharm STABILIZED INJECTION SOLUTIONS FROM PIROXICAM
ITMI20040235A1 (en) * 2004-02-13 2004-05-13 Therapicon Srl PHARMACEUTICAL PREPARATION FOR THE ORAL CABLE

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093999A2 (en) * 1982-05-08 1983-11-16 Gödecke Aktiengesellschaft Pharmaceutical formulations of oxicam derivatives, and process for preparing them
EP0093999A3 (en) * 1982-05-08 1985-05-15 Godecke Aktiengesellschaft Pharmaceutical formulations of oxicam derivatives, and process for preparing them

Also Published As

Publication number Publication date
BE629650A (en) 1900-01-01
GB1072359A (en) 1967-06-14
CH487897A (en) 1970-03-31

Similar Documents

Publication Publication Date Title
IT941365B (en) TRUSS OF BONE
BR7108466D0 (en) LOCAL ANESTHETICS AND ACYLXYLIDIDES AND THE PROCESS OF THEIR PREPARATION
BE774399A (en) NEW USE OF ADENOSINE DERIVATIVES
FR1400747A (en) Expansion anchor bolt
FR3222M (en) Antidepressant psychotropic drug.
BR6574051D0 (en) PROCESS TO PREPARE SUBSTITUTED AMIDINES AND REACTIONAL DERIVATIVES FROM THE SAME
BR7307461D0 (en) RIDO- (4-3-D) -PIRIMIDIN-4- (3H) -ONAS 2 REPLACED, AND PROCEPROCESS TO PREPARE PIRIDO- (2-3-D), PIRIPO- (3-4-D) AND PISSO TO PREPARE AMINO -NICOTINO-NITRILAS
FR1501679A (en) Anchor bolt
FR2910M (en) New injectable form of phenyl-1-dimethyl-2,3-dimethylamino-4-pyrazolone-5 ortho-hydroxyquinoline sulfonate useful in influenza and antirhumastimal therapy.
FR3518M (en) New formulations of antibiotics in the tetracycline series.
BR6574917D0 (en) NEW BENZISOTIAZOILS REPLACED AND PROCESS TO PREPARE THE SAME
BE773446A (en) FLUORO-5 PYRIMIDINES
BR6568351D0 (en) NEW PROCESS FOR THE PREPARATION OF 17 ALPHA-ESTERS OF 17-ALPHA-HYDROXY-3-PCTO-DELTA-4-PREGNENS
BR6683481D0 (en) PHARMACOLOGICALLY ACTIVE COMPOUNDS AND THE PROCESS OF OBTAINING THEM
BE764011A (en) ANTIDEPRESSANT AGENTS
SE394675B (en) 2,5-DIMETHYLFURAN-3-CARBONIC ACID CYCLOHEXYLAMIDE WITH FUNGICIDING ACTION
FR1415083A (en) Color alteration inhibitor
BR7301518D0 (en) PROCESS TO PREPARE AN INSECTICIDE AND ACARICIDE COMPOUND
BR7309817D0 (en) AZOIC DYES AND PROCESS TO PREPARE THE SAME
BR6572749D0 (en) PROCESS TO PREPARE L-METHIL-3- (2- (5-NITRO-2-FURIL) VINYL2-1 2 4-TRIAZOLIN-5-ONA AND INTERMEDIATE OF THE SAME
FR3805M (en) New & delta <4> -7α-methyl-17β-hydroxy-19-nor-androstene-3-one usable in therapy.
FR124M (en) New pharmaceutical composition for use in the treatment of hypertension and diuresis.
FR3143M (en) Amides of β-phenyl-β-oxypropionic and β-aceto-amido-β-phenylpropionic acids.
FR1162M (en) Medicinal product applicable in the therapy of hypertension.
BR6905373D0 (en) NEW PROCESS FOR THE BUILDING OF AMBULATORY SCHOOLS, WAREHOUSES AND OTHERS